CIMINI, Donatella
 Distribuzione geografica
Continente #
EU - Europa 1.426
NA - Nord America 1.290
AS - Asia 191
AF - Africa 5
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.915
Nazione #
US - Stati Uniti d'America 1.285
IE - Irlanda 532
IT - Italia 240
UA - Ucraina 187
GB - Regno Unito 163
DE - Germania 121
CN - Cina 94
TR - Turchia 69
FI - Finlandia 50
SE - Svezia 40
GR - Grecia 37
BE - Belgio 23
NL - Olanda 11
PK - Pakistan 8
FR - Francia 7
CH - Svizzera 6
IN - India 6
CA - Canada 5
BJ - Benin 4
ES - Italia 4
VN - Vietnam 4
IR - Iran 3
JP - Giappone 3
CL - Cile 2
HK - Hong Kong 2
AT - Austria 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
PT - Portogallo 1
TW - Taiwan 1
Totale 2.915
Città #
Dublin 532
Jacksonville 289
Chandler 254
Ann Arbor 68
Princeton 62
Bremen 61
Caserta 53
Roxbury 49
Medford 46
New York 34
Naples 32
Boardman 26
Wilmington 26
Woodbridge 26
San Mateo 23
Napoli 22
Brussels 19
Cambridge 18
Beijing 13
Des Moines 13
Ashburn 11
Nanjing 11
Auburn Hills 8
Islamabad 8
Nanchang 8
Amsterdam 7
Boydton 7
Solopaca 7
Shanghai 6
Zhengzhou 6
Crispano 5
Marano di Napoli 5
Taiyuan 5
Boscotrecase 4
Dong Ket 4
Guangzhou 4
Los Angeles 4
Norwalk 4
Redwood City 4
Rome 4
Santa Maria Capua Vetere 4
Shenyang 4
Wavre 4
Elora 3
Groningen 3
Haikou 3
Houston 3
Lanzhou 3
Lappeenranta 3
San Martino Valle Caudina 3
Seattle 3
Segrate 3
Tianjin 3
Tokyo 3
Amorosi 2
Berlin 2
Brusciano 2
Cardito 2
Cerro Maggiore 2
Changchun 2
Chengdu 2
Como 2
Dearborn 2
Hebei 2
Helsinki 2
Istanbul 2
Jinan 2
Kunming 2
Madrid 2
Manassas 2
Milan 2
Mondragone 2
Mumbai 2
Nola 2
Nuremberg 2
Padova 2
Padula 2
Pune 2
Salerno 2
Santa Clara 2
Venice 2
Afragola 1
Arlington 1
Aveiro 1
Aversa 1
Baotou 1
Barrie 1
Bergamo 1
Binasco 1
Calitri 1
Camerino 1
Changsha 1
Düsseldorf 1
Fairfield 1
Ferrara 1
Francolise 1
Frankfurt am Main 1
Fuzhou 1
Gentofte 1
Giulianova 1
Totale 1.906
Nome #
Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications 75
Engineering a branch of the UDP-precursor biosynthesis pathway enhances the production of capsular polysaccharide in Escherichia coli O5:K4:H4. 69
A combined fermentative-chemical approach for the scalable production of pure E. coli monophosphoryl lipid A. 67
Produzione biotecnologica di condroitina 66
Biotechnological production of chondroitin. 64
High-performance CE of Escherichia coli K4 cell surface polysaccharides. 63
Lactobacillus brevis CD2: Fermentation Strategies and Extracellular Metabolites Characterization 61
Microbial production and metabolic engineering of chondroitin and chondroitin sulfate 60
Production of capsular polysaccharide from< i> Escherichia coli K4 60
Application of a 22L scale membrane bioreactor and cross-flow ultrafiltration to obtain purified chondroitin. 59
Production of succinic acid from Basfia succiniciproducens up to the pilot scale from Arundo donax hydrolysate 58
IS-2 mediated overexpression of kfoC in E.coli K4 increases Chondroitin-like capsular polysaccharide production 57
Lactobacillus crispatus L1: high cell density cultivation and exopolysaccharide structure characterization to highlight potentially beneficial effects against vaginal pathogens. BMC Microbiol. 56
Production of a thermophilic maltooligosyl-trehalose synthase in Lactococcus lactis 56
Saccharomyces pastoranius as cell factory to improve glutathione production using novel fermentation strategies 55
High-performance capillary electrophoresis for the determination of glycosaminoglycans-like microbial polysaccharides in biotechnological processes 55
Improved fructosylated chondroitin production by kfoC overexpression in E. coli K4 54
< i> Saccharomyces pastorianus as cell factory to improve glutathione production using novel fermentation strategies 53
Engineering S. equi subsp. zooepidemicus towards concurrent production of hyaluronic acid and chondroitin biopolymers of biomedical interest 53
Lactobacillus plantarum: microfiltration experiments for the production of probiotic biomass to be used in food and nutraceutical preparations. 52
Production of capsular polysaccharide from Escherichia coli K4. 52
Fed Batch strategies to improve the production of CPS from E.coli K4 52
Production of human pro-relaxin H2 in the yeast Pichia pastoris 52
Differential Secretome Profiling of Human Osteoarthritic Synoviocytes Treated with Biotechnological Unsulfated and Marine Sulfated Chondroitins 52
Production and purification of capsular polysaccharide from Escherichia coli K4 for potential biotechnological applications. 50
Molecular weight determination of heparosan- and chondroitin-like capsular polysaccharides: figuring out differences between wild -type and engineered Escherichia coli strains 49
Molecular weight studies on chondroitin-like microbial capsular polysaccharides 49
Saccharomyces pastorianus as cell factory to improve glutathione production using novel fermentation strategies 48
High cell density cultivation of Escherichia coli K4 in a microfiltration bioreactor: a step towards improvement of chondroitin precursor production. 48
Production of succinic acid from arundo donax hydrolysate for bio-based polymers synthesis 47
Protective effect of extractive and biotechnological chondroitin in insulin amyloid and advanced glycation end product-induced toxicity 47
Molecular Weight Determination of Biotechnologically Produced Chondroitin 46
Production of trehalosyl-dextrins from starch exploiting thermostable enzymes 46
Isolation of an Escherichia coli K4 kfoC mutant over-producing capsular chondroitin 45
Bio-Based Succinate Production from Arundo donax Hydrolysate with the New Natural Succinic Acid-Producing Strain Basfia succiniciproducens BPP7 45
Potential of Biofermentative Unsulfated Chondroitin and Hyaluronic Acid in Dermal Repair 45
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection. 43
In vitro model based on human keratinocyte to evaluate relaxin activity on wound healing exploiting time-lapse video microscopy 43
Saccharomyces pastorianus as cell factory to improve glutathione production using novel fermentation strategies 43
In vitro model exploiting time-lapse video microscopy to evaluate relaxin activity and support novel applications 41
Evaluation of unsulfated biotechnological chondroitin in a knee osteoarthritis mouse model as a potential novel functional ingredient in nutraceuticals and pharmaceuticals 40
Metabolic engineering of succinic acid production in Saccharomyces cerevisiae by using integrative metabolic engineering cycle 39
Production of a thermophilic trehalosyl-dextrins forming enzyme in Lactococcus lactis. 38
Homologous overexpression of rfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide. 38
Molecularstudies on capsular polysaccharides biosynthesis 37
Monosaccharide precursors for boosting chondroitin-like capsular polysaccharide production 35
Unsulfated biotechnological chondroitin by itself as well as in combination with high molecular weight hyaluronan improves the inflammation profile in osteoarthritis in vitro model 35
Industrial Systems Biology of Saccharomyces cerevisiae Enables Novel Succinic Acid Cell Factory 34
Production and characterization of a novel exopolysaccharide from Lactobacillus crispatus L1 in high cell density cultivation 34
Development of Semisynthetic, Regioselective Pathways for Accessing the Missing Sulfation Patterns of Chondroitin Sulfate. 31
Production of chondroitin sulfate and chondroitin. 30
Production of glucuronic acid based polysaccharides for biomedical applications by microbial fermentations. 29
Physiological characterization and quantitative proteomic analyses of metabolically engineered E. coli K4 strains with improved pathways for capsular polysaccharide biosynthesis 28
Improved production of succinic acid from Basfia succiniciproducens growing on A-donax and process evaluation through material flow analysis 27
Global transcriptional response of Saccharomyces cerevisiae following deletion of succinate dehydrogenase 27
Microbioreactor (micro-Matrix) potential in aerobic and anaerobic conditions with different industrially relevant microbial strains 27
Timely Supplementation of Hydrogels Containing Sulfated or Unsulfated Chondroitin and Hyaluronic Acid Affects Mesenchymal Stromal Cells Commitment Toward Chondrogenic Differentiation 26
Concentrated buffalo whey as substrate for probiotic cultures and as source of bioactive ingredients: A local circular economy approach towards reuse of wastewaters 26
Production of Succinic Acid From Basfia succiniciproducens 26
Production and purification of higher molecular weight chondroitin by metabolically engineered Escherichia coli K4 strains 25
Chestnut Shells as Waste Material for Succinic Acid Production from Actinobacillus succinogenes 130Z 25
null 23
No Waste from Waste: Membrane-Based Fractionation of Second Cheese Whey for Potential Nutraceutical and Cosmeceutical Applications, and as Renewable Substrate for Fermentation Processes Development 22
null 22
Isolation of new cellulase and xylanase producing strains and application to lignocellulosic biomasses hydrolysis and succinic acid production. 22
null 18
Calcium/calmodulin-dependent kinases can regulate the TSH expression in the rat pituitary 18
Molecular Fingerprint of Human Pathological Synoviocytes in Response to Extractive Sulfated and Biofermentative Unsulfated Chondroitins 17
Statistical optimization of levan: Influence of the parameter on levan structure and angiotensin I-converting enzyme inhibitory 17
Antioxidants positively regulate obesity dependent circRNAs - sperm quality - functional axis 16
Production of chondroitin precursor on 22L membrane reactor and its purification exploiting cross-flow ultrafiltration. 15
Limosilactobacillus fermentum from buffalo milk is suitable for potential biotechnological process development and inhibits Helicobacter pylori in a gastric epithelial cell model 14
Optimization of growth of Levilactobacillus brevis SP 48 and in vitro evaluation of the effect of viable cells and high molecular weight potential postbiotics on Helicobacter pylori 13
Production of a thermophilic trehalosyl-dextrins forming enzyme in lactococcus lactis 10
Novel Insights into circRNA Saga Coming from Spermatozoa and Epididymis of HFD Mice 9
In Vitro Evaluation of the Most Active Probiotic Strains Able to Improve the Intestinal Barrier Functions and to Prevent Inflammatory Diseases of the Gastrointestinal System 8
Evaluation of Different Activity of Lactobacillus spp. against Two Proteus mirabilis Isolated Clinical Strains in Different Anatomical Sites In Vitro: An Explorative Study to Improve the Therapeutic Approach 8
Grape Stalk Valorization: An Efficient Re-Use of Lignocellulosic Biomass through Hydrolysis and Fermentation to Produce Lactic Acid from Lactobacillus rhamnosus IMC501 7
Thermophilic biocatalysts for one-step conversion of citrus waste into lactic acid 6
Novel hydroxyectoines based formulations are suitable for preserving viability of Limosilactobacillus fermentum, Levilactobacillus brevis SP-48 and Bifidobacterium lactis HN019 during freeze-drying and storage, and in simulated gastrointestinal fluids 5
Biotechnological advances in the synthesis of modified chondroitin towards novel biomedical applications 2
Totale 3.065
Categoria #
all - tutte 11.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 7 6
2019/2020325 64 49 3 17 49 7 69 10 23 16 15 3
2020/2021453 44 2 53 55 54 12 63 46 2 53 47 22
2021/2022411 26 6 2 7 123 5 10 8 21 47 37 119
2022/20231.077 80 18 29 93 135 93 4 53 524 9 16 23
2023/2024322 37 12 21 25 120 42 24 23 4 10 4 0
Totale 3.065